High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for UncomplicatedPlasmodium falciparumMalaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series | Zendy

Klara Sondén | Zendy; Katja Wyss | Zendy; Irina Jovel | Zendy; Antero Vieira Silva | Zendy; Anton Pohanka | Zendy; Muhammad Asghar | Zendy; Manijeh Vafa Homann | Zendy; Lars L. Gustafsson | Zendy; Urban Hellgren | Zendy; Anna Färnert | Zendy

Open Access

High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for UncomplicatedPlasmodium falciparumMalaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series

Author(s) -

Klara Sondén,

Katja Wyss,

Irina Jovel,

Antero Vieira Silva,

Anton Pohanka,

Muhammad Asghar,

Manijeh Vafa Homann,

Lars L. Gustafsson,

Urban Hellgren,

Anna Färnert

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw710

Subject(s) - medicine , artemether/lumefantrine , malaria , regimen , mefloquine , lumefantrine , artemisinin , plasmodium falciparum , artesunate , artemether , combination therapy , retrospective cohort study , quinine , atovaquone , dosing , surgery , immunology

Artemisinin-based combination therapy (ACT) is the first-line treatment of Plasmodium falciparum malaria. Since the introduction of artemether-lumefantrine (AL) for treatment of uncomplicated malaria in Sweden, treatment failures have been reported in adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research